| 摘要 |
<p>The invention concerns nucleic sequences derived from a human erythrovirus, their fragments and their applications as diagnostic reagent and as immunogenic agent. Said sequences are selected among the sequences having a ≥ 10 % genetic divergence over the whole genome with respect to the B19 erythrovirus sequences, the sequence SEQ ID NO:1 and the nucleotide sequences capable of being hybridized with said sequence ID NO:1.</p> |
